If you suspect your constipation is a side effect of your medication, you can report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
In rodent models, lixisenatide, liraglutide, and exenatide have been reported to significantly reduce brain levels of the pro-inflammatory cytokine, tumor necrosis factor (TNF-) [71,72,73]
Zepbound is approved for chronic weight management in certain adults, while Mounjaro is approved to improve blood sugar control in adults with type 2 diabetes
However, emerging research suggests these medications may also lower the risk of conditions such as Alzheimer's disease, addiction, sleep apnea, seizures, and bacterial infections
Fig.5 Efficacy Assessment of Semaglutide in the CDHFD-Induced MASH Rat Models